GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » SHL Telemedicine Ltd (LTS:0QMX) » Definitions » Cash Flow from Financing

SHL Telemedicine (LTS:0QMX) Cash Flow from Financing : CHF12.41 Mil (TTM As of Dec. 2023)


View and export this data going back to 2014. Start your Free Trial

What is SHL Telemedicine Cash Flow from Financing?

Cash from financing is the cash generated/spent from financial activities such as share issuance (buy back), debt issuance (repayment), and dividends paid to preferred and common stockholders.

For the six months ended in Dec. 2023, SHL Telemedicine paid CHF0.00 Mil more to buy back shares than it received from issuing new shares. It spent CHF1.13 Mil paying down its debt. It paid CHF0.00 Mil more to buy back preferred shares than it received from issuing preferred shares. It received CHF0.00 Mil from paying cash dividends to shareholders. It spent CHF1.34 Mil on other financial activities. In all, SHL Telemedicine spent CHF2.47 Mil on financial activities for the six months ended in Dec. 2023.


SHL Telemedicine Cash Flow from Financing Historical Data

The historical data trend for SHL Telemedicine's Cash Flow from Financing can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

SHL Telemedicine Cash Flow from Financing Chart

SHL Telemedicine Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cash Flow from Financing
Get a 7-Day Free Trial Premium Member Only Premium Member Only -11.69 0.64 47.04 -2.13 11.82

SHL Telemedicine Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Cash Flow from Financing Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 15.66 -1.53 -0.66 14.87 -2.47

SHL Telemedicine Cash Flow from Financing Calculation

This is the cash generated/spent from financial activities such as share issuance (buy back), debt issuance (repayment), and dividends paid to preferred and common stockholders. In the calculation of free cash flow, cash from financing is not calculated because it is not related to operating activities.

SHL Telemedicine's Cash from Financing for the fiscal year that ended in Dec. 2023 is calculated as:

SHL Telemedicine's Cash from Financing for the quarter that ended in Dec. 2023 is:


Cash Flow from Financing for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was CHF12.41 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


SHL Telemedicine  (LTS:0QMX) Cash Flow from Financing Explanation

Cash from financing contains six items:

1. Issuance of Stock:
A company may raise cash from issuing new shares. Issuance of stock represents the cash inflow from offering common stock, which is the additional capital contribution to the entity during the period.

SHL Telemedicine's issuance of stock for the six months ended in Dec. 2023 was CHF0.00 Mil.

2. Repurchase of Stock:
A company may raise cash from issuing new shares. It can also use cash to buy back shares. Repurchase of stock represents the cash outflow to reacquire common stock during the period.

SHL Telemedicine's repurchase of stock for the six months ended in Dec. 2023 was CHF0.00 Mil.

3. Net Issuance of Debt:
Net issuance of debt is the cash a company received or spent through debt related activities such as debt issuance or debt repayment. If a company pays down its debt during the period, this number will be negative. If a company issued more debt, it receives cash and this number is positive.

SHL Telemedicine's net issuance of debt for the six months ended in Dec. 2023 was CHF-1.13 Mil. SHL Telemedicine spent CHF1.13 Mil paying down its debt.

4. Net Issuance of Preferred Stock:
A company may raise cash from issuing new preferred shares. It can also use cash to buy back preferred shares. If this number is positive, it means that the company has received more cash from issuing preferred shares than it has paid to buy back preferred shares. If this number is negative, it means that company has paid more cash to buy back preferred shares than it has received for issuing preferred shares.

SHL Telemedicine's net issuance of preferred for the six months ended in Dec. 2023 was CHF0.00 Mil. SHL Telemedicine paid CHF0.00 Mil more to buy back preferred shares than it received from issuing preferred shares.

5. Cash Flow for Dividends:
Cash flow for dividends refers to the payment of cash to shareholders as dividends when the company generates income.

SHL Telemedicine's cash flow for dividends for the six months ended in Dec. 2023 was CHF0.00 Mil. SHL Telemedicine received CHF0.00 Mil from paying cash dividends to shareholders.

6. Other Financing:
Money spent or earned by company from other financial activities.

SHL Telemedicine's other financing for the six months ended in Dec. 2023 was CHF-1.34 Mil. SHL Telemedicine spent CHF1.34 Mil on other financial activities.


SHL Telemedicine Cash Flow from Financing Related Terms

Thank you for viewing the detailed overview of SHL Telemedicine's Cash Flow from Financing provided by GuruFocus.com. Please click on the following links to see related term pages.


SHL Telemedicine (LTS:0QMX) Business Description

Traded in Other Exchanges
Address
90 Yigal Alon Street, Tel Aviv, ISR, 67891
SHL Telemedicine Ltd develops and markets personal telemedicine solutions. It consists of the transmission of medical data by an individual, from a remote location to a medical call center through telecommunication networks. The company offers solutions to subscribing patients, health insurance companies, hospitals, clinics, and physicians. It provides healthcare professional solutions to patients suffering from congestive heart failure, chronic obstructive pulmonary disease, and readmission solutions for reducing heart-related readmissions. In addition, consumer solutions include cardiac monitoring services. The company's geographical segments Israel, Europe, and the rest of the world.

SHL Telemedicine (LTS:0QMX) Headlines

No Headlines